Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma.
Koga
Yuhki
Y
Matsuzaki
Akinobu
A
Suminoe
Aiko
A
Washitoh
Natsumi
N
Hara
Takuya
T
Hara
Toshiro
T
Tajiri
Tatsuro
T
Taguchi
Tomoaki
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D017809:Fatal Outcome; D018197:Hepatoblastoma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015479:Leukemia, Myelomonocytic, Acute / Q000139:chemically induced* / Q000235:genetics / Q000628:therapy; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000235:genetics; D033581:Stem Cell Transplantation; D014178:Translocation, Genetic
D004317:Doxorubicin; D016190:Carboplatin; C027260:pirarubicin; D002945:Cisplatin